Nano-Syringe Delivers Combination, Targeted Brain Cancer Therapy, Rice University Study

Published: Apr 17, 2012

Nanomedicine researchers at the Methodist Neurological Institute and Rice University have developed a way to selectively kill brain cancer cells by using a tiny syringe to deliver a combination of chemotherapy drugs directly into the cells. These findings will be published in the April 24 issue of the American Chemical Society journal ACS Nano.

Back to news